Parkman Healthcare Partners as of Sept. 30, 2022
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 89 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | 4.9 | $17M | 82k | 209.38 | |
| UnitedHealth (UNH) | 4.0 | $14M | 28k | 505.05 | |
| Danaher Corporation (DHR) | 3.9 | $14M | 53k | 258.29 | |
| Boston Scientific Corporation (BSX) | 3.8 | $14M | 348k | 38.73 | |
| Neurocrine Biosciences (NBIX) | 3.5 | $13M | 117k | 106.21 | |
| Eli Lilly & Co. (LLY) | 3.2 | $11M | 35k | 323.34 | |
| CVS Caremark Corporation (CVS) | 3.2 | $11M | 118k | 95.37 | |
| Ionis Pharmaceuticals (IONS) | 3.0 | $11M | 242k | 44.23 | |
| Seagen | 2.8 | $9.9M | 72k | 136.83 | |
| Haemonetics Corporation (HAE) | 2.4 | $8.6M | 116k | 74.03 | |
| Tenet Healthcare Corp Com New (THC) | 2.3 | $8.2M | 159k | 51.58 | |
| Xenon Pharmaceuticals (XENE) | 2.3 | $8.0M | 223k | 36.10 | |
| Anthem (ELV) | 2.2 | $7.8M | 17k | 454.23 | |
| Peregrine Pharmaceuticals (CDMO) | 2.2 | $7.7M | 405k | 19.12 | |
| Concert Pharmaceuticals I equity | 2.2 | $7.6M | 1.1M | 6.70 | |
| Waters Corporation (WAT) | 2.1 | $7.4M | 28k | 269.53 | |
| Cti Biopharma | 2.0 | $7.0M | 1.2M | 5.82 | |
| Edwards Lifesciences (EW) | 1.9 | $6.8M | 82k | 82.63 | |
| Iqvia Holdings (IQV) | 1.8 | $6.4M | 35k | 181.14 | |
| Deciphera Pharmaceuticals (DCPH) | 1.6 | $5.6M | 302k | 18.50 | |
| R1 RCM (RCM) | 1.5 | $5.2M | 279k | 18.53 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.4 | $4.9M | 121k | 40.80 | |
| Alphatec Hldgs Com New (ATEC) | 1.4 | $4.8M | 545k | 8.74 | |
| Natera (NTRA) | 1.3 | $4.6M | 105k | 43.82 | |
| Rhythm Pharmaceuticals (RYTM) | 1.3 | $4.6M | 188k | 24.50 | |
| Day One Biopharmaceuticals I (DAWN) | 1.2 | $4.2M | 212k | 20.03 | |
| Procept Biorobotics Corp (PRCT) | 1.2 | $4.2M | 101k | 41.46 | |
| Insulet Corporation (PODD) | 1.1 | $3.9M | 17k | 229.39 | |
| Sutro Biopharma (STRO) | 1.1 | $3.8M | 687k | 5.55 | |
| Thermo Fisher Scientific (TMO) | 1.1 | $3.8M | 7.5k | 507.20 | |
| Biosante Pharmaceuticals (ANIP) | 1.1 | $3.8M | 118k | 32.14 | |
| Keros Therapeutics (KROS) | 1.1 | $3.8M | 100k | 37.62 | |
| Aclaris Therapeutics (ACRS) | 1.0 | $3.7M | 234k | 15.74 | |
| BioMarin Pharmaceutical (BMRN) | 1.0 | $3.6M | 43k | 84.77 | |
| Apollo Endosurgery | 1.0 | $3.6M | 658k | 5.51 | |
| Arcus Biosciences Incorporated (RCUS) | 1.0 | $3.6M | 138k | 26.16 | |
| Cogent Biosciences (COGT) | 1.0 | $3.5M | 237k | 14.92 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.9 | $3.3M | 323k | 10.22 | |
| Catalent (CTLT) | 0.9 | $3.3M | 45k | 72.36 | |
| Dex (DXCM) | 0.9 | $3.3M | 40k | 80.53 | |
| Irhythm Technologies (IRTC) | 0.9 | $3.2M | 26k | 125.27 | |
| Nanostring Technologies (NSTGQ) | 0.9 | $3.1M | 243k | 12.77 | |
| Schrodinger (SDGR) | 0.9 | $3.1M | 124k | 24.98 | |
| Supernus Pharmaceuticals (SUPN) | 0.9 | $3.0M | 90k | 33.85 | |
| Mannkind Corp Com New (MNKD) | 0.8 | $2.9M | 925k | 3.09 | |
| Imago Biosciences | 0.8 | $2.8M | 189k | 15.05 | |
| Intuitive Surgical Com New (ISRG) | 0.8 | $2.8M | 15k | 187.47 | |
| Cooper Cos Com New | 0.8 | $2.8M | 11k | 263.89 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.8 | $2.8M | 40k | 70.33 | |
| Karuna Therapeutics Ord | 0.8 | $2.7M | 12k | 224.92 | |
| Arcellx Common Stock (ACLX) | 0.7 | $2.6M | 140k | 18.77 | |
| Axogen (AXGN) | 0.7 | $2.4M | 200k | 11.92 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $2.2M | 11k | 200.13 | |
| Immunic (IMUX) | 0.6 | $2.1M | 658k | 3.16 | |
| Rxsight (RXST) | 0.6 | $2.0M | 167k | 12.00 | |
| Esperion Therapeutics (ESPR) | 0.6 | $2.0M | 296k | 6.70 | |
| Fulcrum Therapeutics (FULC) | 0.5 | $1.9M | 235k | 8.09 | |
| Akoya Biosciences (AKYA) | 0.5 | $1.9M | 162k | 11.75 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.5 | $1.9M | 81k | 23.27 | |
| Performant Finl (PFMT) | 0.5 | $1.9M | 1.0M | 1.85 | |
| Landec Corporation (LFCR) | 0.5 | $1.8M | 202k | 8.89 | |
| Transmedics Group (TMDX) | 0.5 | $1.8M | 42k | 41.74 | |
| X4 Pharmaceuticals (XFOR) | 0.5 | $1.6M | 950k | 1.71 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.5 | $1.6M | 126k | 12.84 | |
| Repro-Med Systems (KRMD) | 0.4 | $1.5M | 684k | 2.23 | |
| Madrigal Pharmaceuticals (MDGL) | 0.4 | $1.4M | 22k | 64.98 | |
| Liquidia Corporation Com New (LQDA) | 0.4 | $1.4M | 255k | 5.44 | |
| 89bio (ETNB) | 0.4 | $1.3M | 225k | 5.79 | |
| Silence Therapeutics Ads (SLN) | 0.4 | $1.3M | 128k | 10.03 | |
| Veracyte (VCYT) | 0.3 | $1.0M | 61k | 16.61 | |
| Beyond Air (XAIR) | 0.3 | $941k | 126k | 7.44 | |
| Tela Bio (TELA) | 0.3 | $940k | 110k | 8.52 | |
| Pepgen (PEPG) | 0.3 | $908k | 100k | 9.08 | |
| Iveric Bio | 0.3 | $897k | 50k | 17.94 | |
| Mirum Pharmaceuticals (MIRM) | 0.3 | $891k | 42k | 21.02 | |
| Establishment Labs Holdings Ord (ESTA) | 0.2 | $829k | 15k | 54.64 | |
| Opiant Pharmaceuticals | 0.2 | $823k | 77k | 10.75 | |
| Harvard Bioscience (HBIO) | 0.2 | $782k | 305k | 2.56 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.2 | $729k | 304k | 2.40 | |
| Miragen Therapeutics (VRDN) | 0.2 | $725k | 35k | 20.50 | |
| Travere Therapeutics (TVTX) | 0.2 | $655k | 27k | 24.66 | |
| Codexis (CDXS) | 0.2 | $638k | 105k | 6.06 | |
| Plus Therapeutics Com New | 0.2 | $590k | 1.3M | 0.45 | |
| Edgewise Therapeutics (EWTX) | 0.1 | $492k | 50k | 9.84 | |
| Alpha Teknova (TKNO) | 0.1 | $406k | 121k | 3.34 | |
| Neuronetics (STIM) | 0.1 | $273k | 86k | 3.18 | |
| Biolinerx Sponsored Ads (BLRX) | 0.1 | $267k | 289k | 0.92 | |
| Sientra | 0.1 | $239k | 374k | 0.64 | |
| Unity Biotechnology | 0.0 | $160k | 404k | 0.40 |
